10 results
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
Adult Clinical Evaluation ... 7-28% -> Incr risk ... complications, ... #Guide #Diagnosis ... #Algorithm #Protocol
Evaluation and Management of Hyperkalemia

As with hypokalemia, the immediate danger of hyperkalemia is its effect on
Evaluation and Management ... The absence of symptoms ... their increased risk ... #Diagnosis #Hyperkalemia ... #Evaluation #Algorithm
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Algorithm • 40- ... clinical remission • Risk ... diet/deficiency symptoms ... #Algorithm #diagnosis ... #management
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
initially requires an evaluation ... to respiratory risk ... of respiratory symptoms ... #Diagnosis #Management ... #Differences #Algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Evaluation Major ... adverse events or complications ... event, follow ACC algorithm ... medical and surgical management ... #diagnosis
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
asymptomatic at diagnosis ... are at increased risk ... Care focuses on symptom ... clinical trial evaluation ... #management #summary
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
carry treatment implications ... acidosis is very mild ... diabetic as you risk ... #diagnosis #differential ... #algorithm #management
Immune Checkpoint Inhibitor-Mediated Colitis
Grade of Disease Severity:
 • G1: Increase < 4 BMs/day over baseline; mild
intervention indicated Diagnostic ... Evaluation: G2- ... (MR/CT) if c/f complication ... CheckpointInhibitor #Colitis #diagnosis ... #management #algorithm
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
and complications ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... #management #hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... of clonal evolution ... of death from complications ... disease-associated symptoms ... median age at diagnosis